Evidence map›Paper›PMID 42865984›Full record

ArticleACS medicinal chemistry letters2026

Toward Rational Design of Orally Bioavailable PROTACs: Development of a Fully Computational Oral Absorption Score.

Arman Fathizadeh, Erika M V Araujo, Nicholas T Cockroft, Brett R Beno, Keith R Hornberger

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arman FathizadehArvinas Operations, Inc., New Haven, Connecticut 06511, United States.ORCID https://orcid.org/0009-0002-5873-6179
Erika M V AraujoArvinas Operations, Inc., New Haven, Connecticut 06511, United States.ORCID https://orcid.org/0009-0007-8781-9375
Nicholas T CockroftArvinas Operations, Inc., New Haven, Connecticut 06511, United States.
Brett R BenoArvinas Operations, Inc., New Haven, Connecticut 06511, United States.
Keith R HornbergerArvinas Operations, Inc., New Haven, Connecticut 06511, United States.ORCID https://orcid.org/0000-0002-6127-2814

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achieving adequate oral absorption for proteolysis-targeting chimeras (PROTACs) remains challenging due to their size, polarity, and conformational complexity. While existing approaches often rely on physicochemical property space or chameleonicity-driven models, a generalizable framework for guiding compound design prior to synthesis is lacking. Here, we introduce comPASS, a fully computational scoring function derived from molecular dynamics-based descriptors that is designed to capture the balance between molecular extension and exposed polarity through normalized radius of gyration and three-dimensional polar surface area of PROTACs. Across mouse and rat data sets, comPASS shows consistent predictive performance and may facilitate prioritization of compounds at early design stages. We further show that within the data sets studied, extended molecular geometries are associated with improved absorption, when increased elongation is not driven solely by increases in molecular size. To assess the potential benefit of incorporating experimental information, we also developed an enhanced variant, ePASS, which incorporates experimental polar surface area (EPSA) and lipophilicity terms consistent with prior approaches and shows promising predictive performance relative to similar literature methods. Together, these results establish practical guidance for presynthetic prioritization of PROTACs and provide a potential framework for guiding the design of orally absorbed PROTACs.

Indexed as

3D polar surface areamolecular dynamicsoral absorptionPROTACsradius of gyration

Identifiers

PMID42865984
PMCPMC13656284

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.